Cancer
Researchers find potential new treatment target for deadly brain cancer
A team of researchers has found a key player in brain tumour formation that may lead to new therapies for...
Expand HPV vaccination programs in Canada to include males
Expanding human papillomavirus (HPV) vaccination programs to include males in Canada will help protect them against HPV-related cancers, according to...
Medical literature may overemphasize role of hospital volume in patient outcomes
HOUSTON – (April 25, 2016) – Current medical research and literature may be overemphasizing the role that hospital volume plays...
New understanding of enzymes could help to develop new drugs to treat diseases
An image of the HDAC enzyme is available here: https://www.dropbox.com/sh/tafbpgai7ufo1hk/AAA3a1vCIEApA3srynHXnKfta?dl=0 New knowledge about the mechanism of specific protein complexes in...
Dr. Ming Zhou, featured speaker in Solute Carrier Proteins symposium at the NY Academy of Sciences
To work properly, the cells in our body use carrier proteins to control the transport of ions, such as potassium,...
World-class oral presentations featured at ARRS 2016 Annual Meeting
Leesburg, VA, April 25, 2016– Oral presentations delivered by some of the world's most renowned researchers and radiologists were among...
Vitamin D insufficiency, low rate of DNA methylation in black teens may increase disease risk
AUGUSTA, Ga. – Low levels of vitamin D in black teens correlates with low activity of a major mechanism for...
Chronic inflammation leads to imbalanced blood system and potentially cancer risk
A study published today in the journal Nature Cell Biology shows that chronic exposure to an inflammatory "emergency" signal, interleukin-1,...
Key mechanism identified in brain tumor growth
A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new...
Top tobacco control experts to FDA: Studies of e-cigs suggest more benefit than harm
WASHINGTON — Seven top international tobacco control experts are prompting regulators at the U.S. Food and Drug Administration (FDA) to...
Identification of therapeutic targets in multiple myeloma
Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs. Additionally, many patients experience disease relapse,...
Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer
Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells. The...
VCU Massey researchers uncover process that drives prostate cancer metastasis
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps...
The cell copying machine: How daughters look like their mothers
Tiny structures in our cells, called centrioles, control both cell division and motility. The number of these structures is highly...
Researchers identify new mechanism to target ‘undruggable’ cancer gene
(NEW YORK, NY, April 18, 2016) — RAS genes are mutated in more than 30 percent of human cancers and...
Young adult survivors of childhood cancer report feeling middle-aged
BOSTON (April 21, 2016) – Do survivors of childhood cancer return to normal health as they grow up? According to...
No risk association observed for anthracycline chemotherapy, cognitive decline
New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according...
No increased risk of fatal CV events for breast cancer patients on newer hormone therapy
PASADENA, Calif., April 21, 2016 –In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy...
Wellderly study suggests link between cognitive decline genes and healthy aging
LA JOLLA, Calif. – An eight-year-long accrual and analysis of the whole genome sequences of healthy elderly people, or "Wellderly,"...
Study finds explanation for some treatment-resistant breast cancers
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in...